Skip to content

Evaluating the Role of Neuroinflammation in Low Back Pain

CompletedPhase 2NCT03106740
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

In this research, the study team will use brain imaging to evaluate the presence of neuroinflammation in the brains and spinal cords of patients with low back pain. The efficacy of minocycline use for low back pain treatment will also be evaluated by observing whether short-term minocycline administration will reduce neuroinflammation and low back pain symptoms.

Study details

Official title
Imaging Glia-mediated NeuroInflammation and Treatment Efficacy (the IGNITE Study)
Conditions
Interventions
  • Drug: Minocycline Hydrochloride 100mg Capsule
  • Diagnostic test: Magnetic Resonance-Positron Emission Tomography Imaging
  • Other: Placebo Capsule
Sponsor
Marco Loggia
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Organization
Massachusetts General Hospital
Start date
2017-10-10
Primary completion
2024-04-30
Sex
All
Age range
from 18 Years to 75 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * the ability to give written informed consent * fluency in English * on a stable pain treatment * Chronic or sub-acute low back pain Exclusion Criteria: * no interventional pain procedures during drug trial * contraindications to MRI and PET scanning (including presence of a cardiac pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the head or previous neurosurgery, prosthetic heart valves, claustrophobia) * pregnancy or breast feeding * any use of recreational drugs in the past 6 months * allergy to minocycline or other tetracyclines, or taking medications known to interact with minocycline * any other contraindications to minocycline administration

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03106740